- Investing Ideas
- Japanese Pharmaceuticals & Biotech Healthy potentially undervalued
Japanese Pharmaceuticals & Biotech Healthy potentially undervalued
Results
9
Companies which are potentially undervalued and in an acceptable financial position.
9 companies
Kissei Pharmaceutical
Market Cap: JP¥188.8b
Researches, develops, manufactures, and sells pharmaceutical products primarily in Japan.
4547
JP¥4,555.00
7D
-4.1%
1Y
23.1%
Chugai Pharmaceutical
Market Cap: JP¥12.3t
Engages in the research, development, manufacture, sale, importation, and exportation of pharmaceuticals in Japan and internationally.
4519
JP¥7,445.00
7D
-15.8%
1Y
-7.1%
Astellas Pharma
Market Cap: JP¥4.3t
Manufactures, markets, imports, and exports pharmaceuticals in Japan and internationally.
4503
JP¥2,385.50
7D
-7.2%
1Y
66.2%
Shionogi
Market Cap: JP¥2.6t
Engages in the research, development, manufacture, and distribution of pharmaceuticals, diagnostic reagents, and medical devices in Japan and internationally.
4507
JP¥3,075.00
7D
-4.3%
1Y
27.9%
Otsuka Holdings
Market Cap: JP¥5.6t
Engages in the pharmaceuticals, nutraceuticals, consumer products, and other businesses worldwide.
4578
JP¥10,645.00
7D
-0.4%
1Y
56.9%
Daiichi Sankyo Company
Market Cap: JP¥4.8t
Manufactures and sells pharmaceutical products in Japan, the United States, Europe, and internationally.
4568
JP¥2,602.50
7D
-13.3%
1Y
-25.9%
Ono Pharmaceutical
Market Cap: JP¥1.1t
Produces, purchases, and sells pharmaceuticals and diagnostic reagents worldwide.
4528
JP¥2,304.50
7D
-5.1%
1Y
39.6%
Santen Pharmaceutical
Market Cap: JP¥530.0b
Engages in the research and development, manufacturing, and marketing of pharmaceuticals and medical devices in Japan, China, Asia, Europe, the Middle East, Africa, and internationally.
4536
JP¥1,647.50
7D
-6.0%
1Y
17.1%
Tsumura
Market Cap: JP¥275.2b
Engages in the production and sale of Kampo extract intermediates and granular Kampo formulations in Japan and internationally.
4540
JP¥3,692.00
7D
-1.4%
1Y
-14.5%